The stock of Elevance Health Inc (ELV) has gone up by 4.86% for the week, with a 4.58% rise in the past month and a 12.68% rise in the past quarter. The volatility ratio for the week is 2.08%, and the volatility levels for the past 30 days are 1.67% for ELV. The simple moving average for the last 20 days is 4.12% for ELV’s stock, with a simple moving average of 12.38% for the last 200 days.
Is It Worth Investing in Elevance Health Inc (NYSE: ELV) Right Now?
Elevance Health Inc (NYSE: ELV) has a price-to-earnings ratio of 20.17x that is above its average ratio. Additionally, the 36-month beta value for ELV is 0.79. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
The public float for ELV is 231.25M and currently, short sellers hold a 0.91% ratio of that float. The average trading volume of ELV on April 25, 2024 was 1.03M shares.
ELV) stock’s latest price update
Elevance Health Inc (NYSE: ELV)’s stock price has gone rise by 0.15 in comparison to its previous close of 532.92, however, the company has experienced a 4.86% increase in its stock price over the last five trading days. Zacks Investment Research reported 2024-04-24 that The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here’s why you should take advantage.
Analysts’ Opinion of ELV
Many brokerage firms have already submitted their reports for ELV stocks, with Barclays repeating the rating for ELV by listing it as a “Overweight.” The predicted price for ELV in the upcoming period, according to Barclays is $584 based on the research report published on March 06, 2024 of the current year 2024.
Morgan Stanley gave a rating of “Overweight” to ELV, setting the target price at $571 in the report published on April 27th of the previous year.
ELV Trading at 4.69% from the 50-Day Moving Average
After a stumble in the market that brought ELV to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -1.00% of loss for the given period.
Volatility was left at 1.67%, however, over the last 30 days, the volatility rate increased by 2.08%, as shares surge +3.19% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +5.64% upper at present.
During the last 5 trading sessions, ELV rose by +4.86%, which changed the moving average for the period of 200-days by +23.43% in comparison to the 20-day moving average, which settled at $513.44. In addition, Elevance Health Inc saw 13.18% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ELV starting from Kendrick Charles Morgan JR, who sale 2,432 shares at the price of $500.46 back on Mar 08 ’24. After this action, Kendrick Charles Morgan JR now owns 15,840 shares of Elevance Health Inc, valued at $1,217,119 using the latest closing price.
Penczek Ronald W, the CAO & Controller of Elevance Health Inc, sale 916 shares at $504.58 during a trade that took place back on Mar 06 ’24, which means that Penczek Ronald W is holding 1,764 shares at $462,195 based on the most recent closing price.
Stock Fundamentals for ELV
Current profitability levels for the company are sitting at:
- 0.22 for the present operating margin
- 0.9 for the gross margin
The net margin for Elevance Health Inc stands at 0.04. The total capital return value is set at 0.56. Equity return is now at value 16.02, with 5.65 for asset returns.
Based on Elevance Health Inc (ELV), the company’s capital structure generated 0.39 points at debt to capital in total, while cash flow to debt ratio is standing at 0.13. The debt to equity ratio resting at 0.65. The interest coverage ratio of the stock is 36.39.
Currently, EBITDA for the company is 1.74 billion with net debt to EBITDA at 0.52. When we switch over and look at the enterprise to sales, we see a ratio of 0.84. The receivables turnover for the company is 9.39for trailing twelve months and the total asset turnover is 1.53. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.37.
Conclusion
In conclusion, Elevance Health Inc (ELV) has seen better performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
